FDA Reverses Course on Moderna's mRNA Flu Vaccine Application After Initial Rejection on February 19, 2026 Approved Clinical Trials Moderna Reversal RNA, Messenger United States Food and Drug Administration Vaccines +
FDA Reverses Course and Agrees to Review Moderna's mRNA Flu Vaccine on February 18, 2026 Clinical Trials Moderna Reversal Review [Publication Type] RNA, Messenger United States Food and Drug Administration Vaccines +
Personalizing Metabolic Care with Digital Twins: Recent Developments on August 28, 2025 Administration occupational activities Artificial Intelligence Biological Markers Diabetes digital twins Health care facility metabolic health Obesity Precision Medicine Reversal +
DOGE Reverses Course on FDA Facility Closures, Including Major St. Louis Quality Lab on March 25, 2025 cost-cutting DOGE drug quality Laboratory Reversal St. Louis terminations United States Food and Drug Administration +